Difference between revisions of "Streptococcus agalactiae"
Jump to navigation
Jump to search
Yang Zhang (talk | contribs) |
|||
| Line 53: | Line 53: | ||
*'''Institute''': Department of Infectious Diseases, National Institute of Health, Av. Padre Cruz, 1649–016, Lisbon, Portugal | *'''Institute''': Department of Infectious Diseases, National Institute of Health, Av. Padre Cruz, 1649–016, Lisbon, Portugal | ||
===Citation Statistics=== | ===Citation Statistics=== | ||
| − | Cited by ''' | + | Cited by '''21''' (Based on Google Scholar [2017-08-10]) |
| + | |||
=='''References'''== | =='''References'''== | ||
<references> | <references> | ||
Revision as of 09:04, 11 August 2017
Contents
Description
- Streptococcus agalactiae, group B streptococci (GBS), is a leading cause of bacterial sepsis and meningitis in neonates from industrialized countries, and an emerging pathogen in nonpregnant adults. GBS expression studies allowed the identification and characterization of virulence factors and a better understanding of the host pathogen–environment interactions [1].
- Common Name: Unknown
- NCBI Taxonomy
Growth Conditions
Internal Control Genes
| Gene Symbol | Gene Name | Application Scope | Accession Number | Primers (5'-3') [Forward/Reverse] |
Size [bp] | Tm [℃] | Detection |
|---|---|---|---|---|---|---|---|
| recA[1] | Recombinase A |
|
NA |
|
67 | 60 | SYBR |
| sdhA[1] | Serine dehydratase |
|
NA |
|
82 | 60 | SYBR |
Moleculer types
- mRNA
Evaluation Methods
Contact
- Name: J.P. Gomes
- Email: j.paulo.gomes@insa.min-saude.pt
- Institute: Department of Infectious Diseases, National Institute of Health, Av. Padre Cruz, 1649–016, Lisbon, Portugal
Citation Statistics
Cited by 21 (Based on Google Scholar [2017-08-10])
References
- ↑ 1.0 1.1 1.2 Florindo C, Ferreira R, Borges V, Spellerberg B, Gomes JP, Borrego MJ. Selection of reference genes for real-time expression studies in Streptococcus agalactiae. J Microbiol Methods. 2012 Sep;90(3):220-7.
